nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—Vismodegib—skin cancer	0.0816	0.193	CbGbCtD
Boceprevir—CYP3A4—Imiquimod—skin cancer	0.0705	0.167	CbGbCtD
Boceprevir—CYP3A4—Temozolomide—skin cancer	0.0705	0.167	CbGbCtD
Boceprevir—CYP3A4—Vismodegib—skin cancer	0.0489	0.116	CbGbCtD
Boceprevir—ABCB1—Dactinomycin—skin cancer	0.0429	0.101	CbGbCtD
Boceprevir—CYP3A4—Vemurafenib—skin cancer	0.0386	0.0915	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—skin cancer	0.034	0.0805	CbGbCtD
Boceprevir—ABCB1—Docetaxel—skin cancer	0.0221	0.0524	CbGbCtD
Boceprevir—CTSL—Trafficking and processing of endosomal TLR—TLR7—skin cancer	0.0176	0.168	CbGpPWpGaD
Boceprevir—CTSV—Trafficking and processing of endosomal TLR—TLR7—skin cancer	0.0176	0.168	CbGpPWpGaD
Boceprevir—CTSK—Trafficking and processing of endosomal TLR—TLR7—skin cancer	0.0146	0.139	CbGpPWpGaD
Boceprevir—CYP3A4—Docetaxel—skin cancer	0.0133	0.0314	CbGbCtD
Boceprevir—CTSK—leg—skin cancer	0.0122	0.0681	CbGeAlD
Boceprevir—CTSK—forelimb—skin cancer	0.0122	0.0676	CbGeAlD
Boceprevir—CTSS—Trafficking and processing of endosomal TLR—TLR7—skin cancer	0.012	0.114	CbGpPWpGaD
Boceprevir—CTSK—hindlimb—skin cancer	0.0109	0.0608	CbGeAlD
Boceprevir—CTSK—appendage—skin cancer	0.00938	0.0522	CbGeAlD
Boceprevir—CTSV—hair follicle—skin cancer	0.00905	0.0503	CbGeAlD
Boceprevir—CMA1—blood vessel—skin cancer	0.00811	0.0451	CbGeAlD
Boceprevir—CTSV—nipple—skin cancer	0.00614	0.0341	CbGeAlD
Boceprevir—CTSK—hair follicle—skin cancer	0.00557	0.031	CbGeAlD
Boceprevir—CMA1—Peptide hormone metabolism—EXOC2—skin cancer	0.00525	0.05	CbGpPWpGaD
Boceprevir—CTSL—nipple—skin cancer	0.00501	0.0279	CbGeAlD
Boceprevir—CTSL—neck—skin cancer	0.00496	0.0276	CbGeAlD
Boceprevir—CMA1—connective tissue—skin cancer	0.00416	0.0231	CbGeAlD
Boceprevir—CTSV—skin of body—skin cancer	0.00393	0.0218	CbGeAlD
Boceprevir—CTSK—nipple—skin cancer	0.00378	0.021	CbGeAlD
Boceprevir—CMA1—skin of body—skin cancer	0.00375	0.0209	CbGeAlD
Boceprevir—CTSV—mammalian vulva—skin cancer	0.00358	0.0199	CbGeAlD
Boceprevir—CTSL—connective tissue—skin cancer	0.00355	0.0198	CbGeAlD
Boceprevir—CMA1—mammalian vulva—skin cancer	0.00342	0.019	CbGeAlD
Boceprevir—CTSL—epithelium—skin cancer	0.00337	0.0188	CbGeAlD
Boceprevir—CTSS—nipple—skin cancer	0.00331	0.0184	CbGeAlD
Boceprevir—CTSS—neck—skin cancer	0.00327	0.0182	CbGeAlD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—MITF—skin cancer	0.00324	0.0309	CbGpPWpGaD
Boceprevir—CTSL—skin of body—skin cancer	0.00321	0.0178	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—skin cancer	0.00318	0.0177	CbGeAlD
Boceprevir—CTSV—female reproductive system—skin cancer	0.00307	0.0171	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—skin cancer	0.00304	0.0169	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—PTCH1—skin cancer	0.00294	0.028	CbGpPWpGaD
Boceprevir—CMA1—female reproductive system—skin cancer	0.00293	0.0163	CbGeAlD
Boceprevir—CTSL—mammalian vulva—skin cancer	0.00293	0.0163	CbGeAlD
Boceprevir—CTSK—connective tissue—skin cancer	0.00268	0.0149	CbGeAlD
Boceprevir—CTSV—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00261	0.0249	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00261	0.0249	CbGpPWpGaD
Boceprevir—CTSL—lymphoid tissue—skin cancer	0.0026	0.0144	CbGeAlD
Boceprevir—CTSV—head—skin cancer	0.00256	0.0143	CbGeAlD
Boceprevir—CTSL—female reproductive system—skin cancer	0.00251	0.0139	CbGeAlD
Boceprevir—CTSK—skin of body—skin cancer	0.00242	0.0134	CbGeAlD
Boceprevir—CTSS—connective tissue—skin cancer	0.00235	0.013	CbGeAlD
Boceprevir—CTSK—mammalian vulva—skin cancer	0.00221	0.0123	CbGeAlD
Boceprevir—CTSK—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00216	0.0206	CbGpPWpGaD
Boceprevir—CTSS—skin of body—skin cancer	0.00212	0.0118	CbGeAlD
Boceprevir—CTSL—head—skin cancer	0.00209	0.0116	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—skin cancer	0.00196	0.0109	CbGeAlD
Boceprevir—CTSS—mammalian vulva—skin cancer	0.00193	0.0107	CbGeAlD
Boceprevir—CTSK—female reproductive system—skin cancer	0.00189	0.0105	CbGeAlD
Boceprevir—CTSS—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00178	0.017	CbGpPWpGaD
Boceprevir—CTSS—lymphoid tissue—skin cancer	0.00172	0.00954	CbGeAlD
Boceprevir—CMA1—lymph node—skin cancer	0.00171	0.00953	CbGeAlD
Boceprevir—CTSS—female reproductive system—skin cancer	0.00166	0.0092	CbGeAlD
Boceprevir—CTSK—head—skin cancer	0.00158	0.00877	CbGeAlD
Boceprevir—CTSL—lymph node—skin cancer	0.00147	0.00815	CbGeAlD
Boceprevir—CTSS—head—skin cancer	0.00138	0.00769	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—FOXO4—skin cancer	0.00125	0.0119	CbGpPWpGaD
Boceprevir—CTSK—lymph node—skin cancer	0.0011	0.00614	CbGeAlD
Boceprevir—CMA1—Metabolism of proteins—EXOC2—skin cancer	0.000992	0.00945	CbGpPWpGaD
Boceprevir—CTSS—lymph node—skin cancer	0.000968	0.00538	CbGeAlD
Boceprevir—CTSV—Innate Immune System—TLR7—skin cancer	0.000846	0.00806	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR7—skin cancer	0.000846	0.00806	CbGpPWpGaD
Boceprevir—ABCB1—blood vessel—skin cancer	0.000807	0.00449	CbGeAlD
Boceprevir—CMA1—Signaling Pathways—RHOU—skin cancer	0.000744	0.00709	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR7—skin cancer	0.000701	0.00668	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000622	0.00592	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TLR7—skin cancer	0.000577	0.0055	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR7—skin cancer	0.000493	0.00469	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR7—skin cancer	0.000493	0.00469	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FOXO4—skin cancer	0.000436	0.00415	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FOXO4—skin cancer	0.000436	0.00415	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FOXO4—skin cancer	0.000419	0.00399	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FOXO4—skin cancer	0.000419	0.00399	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—NRAS—skin cancer	0.000416	0.00396	CbGpPWpGaD
Boceprevir—CYP3A4—female reproductive system—skin cancer	0.000412	0.00229	CbGeAlD
Boceprevir—CTSK—Immune System—TLR7—skin cancer	0.000408	0.00389	CbGpPWpGaD
Boceprevir—ABCB1—epithelium—skin cancer	0.000393	0.00218	CbGeAlD
Boceprevir—CMA1—Signaling Pathways—PTCH2—skin cancer	0.000363	0.00346	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FOXO4—skin cancer	0.000361	0.00344	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—KRAS—skin cancer	0.000358	0.00341	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FOXO4—skin cancer	0.000347	0.0033	CbGpPWpGaD
Boceprevir—ABCB1—mammalian vulva—skin cancer	0.000341	0.0019	CbGeAlD
Boceprevir—CTSS—Immune System—TLR7—skin cancer	0.000336	0.0032	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—skin cancer	0.000313	0.00298	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—skin cancer	0.000313	0.00298	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—skin cancer	0.000304	0.0029	CbGpPWpGaD
Boceprevir—ABCB1—lymphoid tissue—skin cancer	0.000303	0.00168	CbGeAlD
Boceprevir—Eye disorder—Temozolomide—skin cancer	0.000299	0.00102	CcSEcCtD
Boceprevir—Tinnitus—Temozolomide—skin cancer	0.000298	0.00102	CcSEcCtD
Boceprevir—Malaise—Bleomycin—skin cancer	0.000298	0.00102	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—FOXO4—skin cancer	0.000297	0.00283	CbGpPWpGaD
Boceprevir—Flushing—Temozolomide—skin cancer	0.000297	0.00102	CcSEcCtD
Boceprevir—Cardiac disorder—Temozolomide—skin cancer	0.000297	0.00102	CcSEcCtD
Boceprevir—Leukopenia—Bleomycin—skin cancer	0.000296	0.00101	CcSEcCtD
Boceprevir—Rhinitis—Fluorouracil—skin cancer	0.000296	0.00101	CcSEcCtD
Boceprevir—Dizziness—Vemurafenib—skin cancer	0.000294	0.00101	CcSEcCtD
Boceprevir—Hypoaesthesia—Fluorouracil—skin cancer	0.000293	0.001	CcSEcCtD
Boceprevir—Pharyngitis—Fluorouracil—skin cancer	0.000293	0.001	CcSEcCtD
Boceprevir—ABCB1—female reproductive system—skin cancer	0.000292	0.00162	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—skin cancer	0.000291	0.00277	CbGpPWpGaD
Boceprevir—Angiopathy—Temozolomide—skin cancer	0.00029	0.000992	CcSEcCtD
Boceprevir—Immune system disorder—Temozolomide—skin cancer	0.000289	0.000988	CcSEcCtD
Boceprevir—Mediastinal disorder—Temozolomide—skin cancer	0.000289	0.000986	CcSEcCtD
Boceprevir—Cough—Bleomycin—skin cancer	0.000288	0.000985	CcSEcCtD
Boceprevir—Chills—Temozolomide—skin cancer	0.000287	0.000982	CcSEcCtD
Boceprevir—Dehydration—Docetaxel—skin cancer	0.000286	0.000978	CcSEcCtD
Boceprevir—Ill-defined disorder—Dactinomycin—skin cancer	0.000286	0.000977	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—FOXO4—skin cancer	0.000286	0.00272	CbGpPWpGaD
Boceprevir—Anaemia—Dactinomycin—skin cancer	0.000285	0.000973	CcSEcCtD
Boceprevir—Vomiting—Vemurafenib—skin cancer	0.000283	0.000967	CcSEcCtD
Boceprevir—Alopecia—Temozolomide—skin cancer	0.000283	0.000967	CcSEcCtD
Boceprevir—Dry skin—Docetaxel—skin cancer	0.000282	0.000964	CcSEcCtD
Boceprevir—Myalgia—Bleomycin—skin cancer	0.000281	0.000961	CcSEcCtD
Boceprevir—Chest pain—Bleomycin—skin cancer	0.000281	0.000961	CcSEcCtD
Boceprevir—Abdominal pain upper—Docetaxel—skin cancer	0.000281	0.00096	CcSEcCtD
Boceprevir—Rash—Vemurafenib—skin cancer	0.000281	0.000959	CcSEcCtD
Boceprevir—Mental disorder—Temozolomide—skin cancer	0.00028	0.000958	CcSEcCtD
Boceprevir—Dermatitis—Vemurafenib—skin cancer	0.00028	0.000958	CcSEcCtD
Boceprevir—Hypersensitivity—Imiquimod—skin cancer	0.00028	0.000955	CcSEcCtD
Boceprevir—Headache—Vemurafenib—skin cancer	0.000279	0.000953	CcSEcCtD
Boceprevir—Erythema—Temozolomide—skin cancer	0.000279	0.000952	CcSEcCtD
Boceprevir—Malnutrition—Temozolomide—skin cancer	0.000279	0.000952	CcSEcCtD
Boceprevir—Breast disorder—Docetaxel—skin cancer	0.000278	0.00095	CcSEcCtD
Boceprevir—Discomfort—Bleomycin—skin cancer	0.000278	0.00095	CcSEcCtD
Boceprevir—Malaise—Dactinomycin—skin cancer	0.000278	0.000949	CcSEcCtD
Boceprevir—Leukopenia—Dactinomycin—skin cancer	0.000276	0.000942	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GLI2—skin cancer	0.000275	0.00262	CbGpPWpGaD
Boceprevir—Nasopharyngitis—Docetaxel—skin cancer	0.000275	0.00094	CcSEcCtD
Boceprevir—Dysgeusia—Temozolomide—skin cancer	0.000273	0.000933	CcSEcCtD
Boceprevir—Asthenia—Imiquimod—skin cancer	0.000272	0.00093	CcSEcCtD
Boceprevir—Confusional state—Bleomycin—skin cancer	0.000272	0.000929	CcSEcCtD
Boceprevir—Back pain—Temozolomide—skin cancer	0.00027	0.000921	CcSEcCtD
Boceprevir—Pruritus—Imiquimod—skin cancer	0.000269	0.000918	CcSEcCtD
Boceprevir—Infection—Bleomycin—skin cancer	0.000268	0.000915	CcSEcCtD
Boceprevir—Dysphagia—Docetaxel—skin cancer	0.000266	0.000909	CcSEcCtD
Boceprevir—Nausea—Vemurafenib—skin cancer	0.000264	0.000903	CcSEcCtD
Boceprevir—Thrombocytopenia—Bleomycin—skin cancer	0.000264	0.000902	CcSEcCtD
Boceprevir—Arrhythmia—Fluorouracil—skin cancer	0.000264	0.0009	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—MC1R—skin cancer	0.000263	0.0025	CbGpPWpGaD
Boceprevir—Vision blurred—Temozolomide—skin cancer	0.000263	0.000897	CcSEcCtD
Boceprevir—Myalgia—Dactinomycin—skin cancer	0.000262	0.000896	CcSEcCtD
Boceprevir—Alopecia—Fluorouracil—skin cancer	0.000261	0.000891	CcSEcCtD
Boceprevir—Diarrhoea—Imiquimod—skin cancer	0.00026	0.000887	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—skin cancer	0.00026	0.00247	CbGpPWpGaD
Boceprevir—Discomfort—Dactinomycin—skin cancer	0.000259	0.000886	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GLI1—skin cancer	0.000259	0.00247	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Temozolomide—skin cancer	0.000259	0.000884	CcSEcCtD
Boceprevir—Anaemia—Temozolomide—skin cancer	0.000258	0.00088	CcSEcCtD
Boceprevir—Erythema—Fluorouracil—skin cancer	0.000257	0.000877	CcSEcCtD
Boceprevir—Agitation—Temozolomide—skin cancer	0.000256	0.000875	CcSEcCtD
Boceprevir—Angioedema—Temozolomide—skin cancer	0.000255	0.00087	CcSEcCtD
Boceprevir—CTSV—Immune System—FOXO4—skin cancer	0.000254	0.00242	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FOXO4—skin cancer	0.000254	0.00242	CbGpPWpGaD
Boceprevir—Pancytopenia—Docetaxel—skin cancer	0.000253	0.000863	CcSEcCtD
Boceprevir—Hypotension—Bleomycin—skin cancer	0.000252	0.000861	CcSEcCtD
Boceprevir—Malaise—Temozolomide—skin cancer	0.000251	0.000859	CcSEcCtD
Boceprevir—Dizziness—Imiquimod—skin cancer	0.000251	0.000858	CcSEcCtD
Boceprevir—Vertigo—Temozolomide—skin cancer	0.00025	0.000856	CcSEcCtD
Boceprevir—Infection—Dactinomycin—skin cancer	0.00025	0.000854	CcSEcCtD
Boceprevir—Leukopenia—Temozolomide—skin cancer	0.000249	0.000852	CcSEcCtD
Boceprevir—Neutropenia—Docetaxel—skin cancer	0.000249	0.00085	CcSEcCtD
Boceprevir—Palpitations—Temozolomide—skin cancer	0.000246	0.000842	CcSEcCtD
Boceprevir—Thrombocytopenia—Dactinomycin—skin cancer	0.000246	0.000841	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000246	0.000839	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SUFU—skin cancer	0.000245	0.00234	CbGpPWpGaD
Boceprevir—ABCB1—head—skin cancer	0.000244	0.00136	CbGeAlD
Boceprevir—Cough—Temozolomide—skin cancer	0.000243	0.000831	CcSEcCtD
Boceprevir—Paraesthesia—Bleomycin—skin cancer	0.000242	0.000827	CcSEcCtD
Boceprevir—Vision blurred—Fluorouracil—skin cancer	0.000242	0.000827	CcSEcCtD
Boceprevir—Vomiting—Imiquimod—skin cancer	0.000241	0.000825	CcSEcCtD
Boceprevir—Weight decreased—Docetaxel—skin cancer	0.000241	0.000822	CcSEcCtD
Boceprevir—Hypertension—Temozolomide—skin cancer	0.000241	0.000822	CcSEcCtD
Boceprevir—Dyspnoea—Bleomycin—skin cancer	0.00024	0.000821	CcSEcCtD
Boceprevir—Rash—Imiquimod—skin cancer	0.000239	0.000818	CcSEcCtD
Boceprevir—Dermatitis—Imiquimod—skin cancer	0.000239	0.000817	CcSEcCtD
Boceprevir—Pneumonia—Docetaxel—skin cancer	0.000239	0.000815	CcSEcCtD
Boceprevir—Headache—Imiquimod—skin cancer	0.000238	0.000812	CcSEcCtD
Boceprevir—Anaemia—Fluorouracil—skin cancer	0.000237	0.000811	CcSEcCtD
Boceprevir—Myalgia—Temozolomide—skin cancer	0.000237	0.000811	CcSEcCtD
Boceprevir—Arthralgia—Temozolomide—skin cancer	0.000237	0.000811	CcSEcCtD
Boceprevir—Infestation NOS—Docetaxel—skin cancer	0.000237	0.00081	CcSEcCtD
Boceprevir—Infestation—Docetaxel—skin cancer	0.000237	0.00081	CcSEcCtD
Boceprevir—Anxiety—Temozolomide—skin cancer	0.000236	0.000808	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000236	0.000805	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000235	0.000803	CcSEcCtD
Boceprevir—Discomfort—Temozolomide—skin cancer	0.000234	0.000801	CcSEcCtD
Boceprevir—Decreased appetite—Bleomycin—skin cancer	0.000234	0.000801	CcSEcCtD
Boceprevir—Neuropathy peripheral—Docetaxel—skin cancer	0.000232	0.000794	CcSEcCtD
Boceprevir—Dry mouth—Temozolomide—skin cancer	0.000232	0.000793	CcSEcCtD
Boceprevir—Stomatitis—Docetaxel—skin cancer	0.000231	0.00079	CcSEcCtD
Boceprevir—Pain—Bleomycin—skin cancer	0.000231	0.000788	CcSEcCtD
Boceprevir—Conjunctivitis—Docetaxel—skin cancer	0.000231	0.000788	CcSEcCtD
Boceprevir—Leukopenia—Fluorouracil—skin cancer	0.00023	0.000785	CcSEcCtD
Boceprevir—Confusional state—Temozolomide—skin cancer	0.000229	0.000784	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000229	0.000783	CcSEcCtD
Boceprevir—Infection—Temozolomide—skin cancer	0.000226	0.000772	CcSEcCtD
Boceprevir—Nausea—Imiquimod—skin cancer	0.000225	0.00077	CcSEcCtD
Boceprevir—Hepatobiliary disease—Docetaxel—skin cancer	0.000224	0.000766	CcSEcCtD
Boceprevir—Epistaxis—Docetaxel—skin cancer	0.000224	0.000764	CcSEcCtD
Boceprevir—Nervous system disorder—Temozolomide—skin cancer	0.000223	0.000762	CcSEcCtD
Boceprevir—Thrombocytopenia—Temozolomide—skin cancer	0.000223	0.000761	CcSEcCtD
Boceprevir—Feeling abnormal—Bleomycin—skin cancer	0.000222	0.000759	CcSEcCtD
Boceprevir—Agranulocytosis—Docetaxel—skin cancer	0.000221	0.000756	CcSEcCtD
Boceprevir—Skin disorder—Temozolomide—skin cancer	0.000221	0.000755	CcSEcCtD
Boceprevir—Hyperhidrosis—Temozolomide—skin cancer	0.00022	0.000751	CcSEcCtD
Boceprevir—Chest pain—Fluorouracil—skin cancer	0.000219	0.000747	CcSEcCtD
Boceprevir—Myalgia—Fluorouracil—skin cancer	0.000219	0.000747	CcSEcCtD
Boceprevir—Decreased appetite—Dactinomycin—skin cancer	0.000219	0.000747	CcSEcCtD
Boceprevir—Fatigue—Dactinomycin—skin cancer	0.000217	0.000741	CcSEcCtD
Boceprevir—Discomfort—Fluorouracil—skin cancer	0.000216	0.000738	CcSEcCtD
Boceprevir—Pain—Dactinomycin—skin cancer	0.000215	0.000735	CcSEcCtD
Boceprevir—Urticaria—Bleomycin—skin cancer	0.000214	0.000732	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—skin cancer	0.000214	0.00204	CbGpPWpGaD
Boceprevir—Rhinitis—Docetaxel—skin cancer	0.000213	0.000729	CcSEcCtD
Boceprevir—Body temperature increased—Bleomycin—skin cancer	0.000213	0.000728	CcSEcCtD
Boceprevir—Hypoaesthesia—Docetaxel—skin cancer	0.000212	0.000724	CcSEcCtD
Boceprevir—Confusional state—Fluorouracil—skin cancer	0.000211	0.000722	CcSEcCtD
Boceprevir—Pharyngitis—Docetaxel—skin cancer	0.000211	0.000722	CcSEcCtD
Boceprevir—CTSK—Immune System—FOXO4—skin cancer	0.00021	0.002	CbGpPWpGaD
Boceprevir—Urinary tract disorder—Docetaxel—skin cancer	0.00021	0.000718	CcSEcCtD
Boceprevir—Oedema peripheral—Docetaxel—skin cancer	0.00021	0.000717	CcSEcCtD
Boceprevir—Connective tissue disorder—Docetaxel—skin cancer	0.000209	0.000715	CcSEcCtD
Boceprevir—Urethral disorder—Docetaxel—skin cancer	0.000209	0.000713	CcSEcCtD
Boceprevir—Infection—Fluorouracil—skin cancer	0.000208	0.000711	CcSEcCtD
Boceprevir—Feeling abnormal—Dactinomycin—skin cancer	0.000207	0.000708	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000207	0.000708	CcSEcCtD
Boceprevir—Insomnia—Temozolomide—skin cancer	0.000206	0.000703	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dactinomycin—skin cancer	0.000206	0.000703	CcSEcCtD
Boceprevir—Nervous system disorder—Fluorouracil—skin cancer	0.000206	0.000702	CcSEcCtD
Boceprevir—Thrombocytopenia—Fluorouracil—skin cancer	0.000205	0.000701	CcSEcCtD
Boceprevir—Visual impairment—Docetaxel—skin cancer	0.000205	0.000701	CcSEcCtD
Boceprevir—Tachycardia—Fluorouracil—skin cancer	0.000205	0.000699	CcSEcCtD
Boceprevir—Paraesthesia—Temozolomide—skin cancer	0.000204	0.000698	CcSEcCtD
Boceprevir—Dyspnoea—Temozolomide—skin cancer	0.000203	0.000693	CcSEcCtD
Boceprevir—Erythema multiforme—Docetaxel—skin cancer	0.000201	0.000688	CcSEcCtD
Boceprevir—Dyspepsia—Temozolomide—skin cancer	0.0002	0.000684	CcSEcCtD
Boceprevir—Eye disorder—Docetaxel—skin cancer	0.000199	0.00068	CcSEcCtD
Boceprevir—Abdominal pain—Dactinomycin—skin cancer	0.000199	0.000679	CcSEcCtD
Boceprevir—Body temperature increased—Dactinomycin—skin cancer	0.000199	0.000679	CcSEcCtD
Boceprevir—Hypersensitivity—Bleomycin—skin cancer	0.000199	0.000679	CcSEcCtD
Boceprevir—Decreased appetite—Temozolomide—skin cancer	0.000198	0.000676	CcSEcCtD
Boceprevir—Flushing—Docetaxel—skin cancer	0.000198	0.000675	CcSEcCtD
Boceprevir—Cardiac disorder—Docetaxel—skin cancer	0.000198	0.000675	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Temozolomide—skin cancer	0.000196	0.000671	CcSEcCtD
Boceprevir—Fatigue—Temozolomide—skin cancer	0.000196	0.00067	CcSEcCtD
Boceprevir—Hypotension—Fluorouracil—skin cancer	0.000196	0.000669	CcSEcCtD
Boceprevir—Constipation—Temozolomide—skin cancer	0.000194	0.000665	CcSEcCtD
Boceprevir—Pain—Temozolomide—skin cancer	0.000194	0.000665	CcSEcCtD
Boceprevir—Asthenia—Bleomycin—skin cancer	0.000193	0.000661	CcSEcCtD
Boceprevir—Angiopathy—Docetaxel—skin cancer	0.000193	0.00066	CcSEcCtD
Boceprevir—Immune system disorder—Docetaxel—skin cancer	0.000192	0.000657	CcSEcCtD
Boceprevir—Mediastinal disorder—Docetaxel—skin cancer	0.000192	0.000656	CcSEcCtD
Boceprevir—Chills—Docetaxel—skin cancer	0.000191	0.000653	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000191	0.000652	CcSEcCtD
Boceprevir—Pruritus—Bleomycin—skin cancer	0.000191	0.000652	CcSEcCtD
Boceprevir—Arrhythmia—Docetaxel—skin cancer	0.00019	0.00065	CcSEcCtD
Boceprevir—Insomnia—Fluorouracil—skin cancer	0.00019	0.000648	CcSEcCtD
Boceprevir—Paraesthesia—Fluorouracil—skin cancer	0.000188	0.000643	CcSEcCtD
Boceprevir—Alopecia—Docetaxel—skin cancer	0.000188	0.000643	CcSEcCtD
Boceprevir—Feeling abnormal—Temozolomide—skin cancer	0.000187	0.00064	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SHH—skin cancer	0.000187	0.00178	CbGpPWpGaD
Boceprevir—Dyspnoea—Fluorouracil—skin cancer	0.000187	0.000638	CcSEcCtD
Boceprevir—Mental disorder—Docetaxel—skin cancer	0.000187	0.000637	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—RASA1—skin cancer	0.000186	0.00177	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Temozolomide—skin cancer	0.000186	0.000636	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	0.000186	0.00177	CbGpPWpGaD
Boceprevir—Malnutrition—Docetaxel—skin cancer	0.000185	0.000633	CcSEcCtD
Boceprevir—Erythema—Docetaxel—skin cancer	0.000185	0.000633	CcSEcCtD
Boceprevir—Hypersensitivity—Dactinomycin—skin cancer	0.000185	0.000633	CcSEcCtD
Boceprevir—Dyspepsia—Fluorouracil—skin cancer	0.000184	0.00063	CcSEcCtD
Boceprevir—Decreased appetite—Fluorouracil—skin cancer	0.000182	0.000622	CcSEcCtD
Boceprevir—Dysgeusia—Docetaxel—skin cancer	0.000181	0.00062	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000181	0.000618	CcSEcCtD
Boceprevir—Urticaria—Temozolomide—skin cancer	0.000181	0.000617	CcSEcCtD
Boceprevir—Asthenia—Dactinomycin—skin cancer	0.00018	0.000617	CcSEcCtD
Boceprevir—Body temperature increased—Temozolomide—skin cancer	0.00018	0.000614	CcSEcCtD
Boceprevir—Abdominal pain—Temozolomide—skin cancer	0.00018	0.000614	CcSEcCtD
Boceprevir—Back pain—Docetaxel—skin cancer	0.000179	0.000613	CcSEcCtD
Boceprevir—Pain—Fluorouracil—skin cancer	0.000179	0.000612	CcSEcCtD
Boceprevir—Muscle spasms—Docetaxel—skin cancer	0.000178	0.000609	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PTCH1—skin cancer	0.000177	0.00169	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SMO—skin cancer	0.000177	0.00169	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FOXO4—skin cancer	0.000173	0.00165	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTGER4—skin cancer	0.000173	0.00165	CbGpPWpGaD
Boceprevir—Feeling abnormal—Fluorouracil—skin cancer	0.000173	0.00059	CcSEcCtD
Boceprevir—Diarrhoea—Dactinomycin—skin cancer	0.000172	0.000588	CcSEcCtD
Boceprevir—Vomiting—Bleomycin—skin cancer	0.000171	0.000586	CcSEcCtD
Boceprevir—Anaemia—Docetaxel—skin cancer	0.000171	0.000585	CcSEcCtD
Boceprevir—ABCB1—lymph node—skin cancer	0.000171	0.000949	CbGeAlD
Boceprevir—Rash—Bleomycin—skin cancer	0.00017	0.000581	CcSEcCtD
Boceprevir—Dermatitis—Bleomycin—skin cancer	0.00017	0.00058	CcSEcCtD
Boceprevir—Hypersensitivity—Temozolomide—skin cancer	0.000168	0.000573	CcSEcCtD
Boceprevir—Urticaria—Fluorouracil—skin cancer	0.000166	0.000569	CcSEcCtD
Boceprevir—Syncope—Docetaxel—skin cancer	0.000166	0.000568	CcSEcCtD
Boceprevir—Leukopenia—Docetaxel—skin cancer	0.000166	0.000567	CcSEcCtD
Boceprevir—Body temperature increased—Fluorouracil—skin cancer	0.000166	0.000566	CcSEcCtD
Boceprevir—Palpitations—Docetaxel—skin cancer	0.000164	0.00056	CcSEcCtD
Boceprevir—Asthenia—Temozolomide—skin cancer	0.000163	0.000558	CcSEcCtD
Boceprevir—Loss of consciousness—Docetaxel—skin cancer	0.000163	0.000557	CcSEcCtD
Boceprevir—Cough—Docetaxel—skin cancer	0.000162	0.000553	CcSEcCtD
Boceprevir—Pruritus—Temozolomide—skin cancer	0.000161	0.00055	CcSEcCtD
Boceprevir—Nausea—Bleomycin—skin cancer	0.00016	0.000547	CcSEcCtD
Boceprevir—Hypertension—Docetaxel—skin cancer	0.00016	0.000547	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—skin cancer	0.00016	0.000546	CcSEcCtD
Boceprevir—Rash—Dactinomycin—skin cancer	0.000159	0.000542	CcSEcCtD
Boceprevir—Myalgia—Docetaxel—skin cancer	0.000158	0.000539	CcSEcCtD
Boceprevir—Arthralgia—Docetaxel—skin cancer	0.000158	0.000539	CcSEcCtD
Boceprevir—Chest pain—Docetaxel—skin cancer	0.000158	0.000539	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000157	0.000535	CcSEcCtD
Boceprevir—Diarrhoea—Temozolomide—skin cancer	0.000156	0.000532	CcSEcCtD
Boceprevir—Hypersensitivity—Fluorouracil—skin cancer	0.000154	0.000528	CcSEcCtD
Boceprevir—Dry mouth—Docetaxel—skin cancer	0.000154	0.000527	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—FOXO4—skin cancer	0.000153	0.00145	CbGpPWpGaD
Boceprevir—Confusional state—Docetaxel—skin cancer	0.000153	0.000521	CcSEcCtD
Boceprevir—Dizziness—Temozolomide—skin cancer	0.00015	0.000514	CcSEcCtD
Boceprevir—Infection—Docetaxel—skin cancer	0.00015	0.000513	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—skin cancer	0.000149	0.00051	CcSEcCtD
Boceprevir—Shock—Docetaxel—skin cancer	0.000149	0.000508	CcSEcCtD
Boceprevir—Nervous system disorder—Docetaxel—skin cancer	0.000148	0.000507	CcSEcCtD
Boceprevir—Pruritus—Fluorouracil—skin cancer	0.000148	0.000507	CcSEcCtD
Boceprevir—Thrombocytopenia—Docetaxel—skin cancer	0.000148	0.000506	CcSEcCtD
Boceprevir—Tachycardia—Docetaxel—skin cancer	0.000148	0.000504	CcSEcCtD
Boceprevir—Skin disorder—Docetaxel—skin cancer	0.000147	0.000502	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000146	0.00139	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—skin cancer	0.000145	0.00138	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NRAS—skin cancer	0.000145	0.00138	CbGpPWpGaD
Boceprevir—Vomiting—Temozolomide—skin cancer	0.000145	0.000494	CcSEcCtD
Boceprevir—Rash—Temozolomide—skin cancer	0.000143	0.00049	CcSEcCtD
Boceprevir—Diarrhoea—Fluorouracil—skin cancer	0.000143	0.00049	CcSEcCtD
Boceprevir—Dermatitis—Temozolomide—skin cancer	0.000143	0.00049	CcSEcCtD
Boceprevir—Headache—Temozolomide—skin cancer	0.000142	0.000487	CcSEcCtD
Boceprevir—Hypotension—Docetaxel—skin cancer	0.000141	0.000483	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—NRAS—skin cancer	0.000139	0.00133	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NRAS—skin cancer	0.000139	0.00133	CbGpPWpGaD
Boceprevir—Dizziness—Fluorouracil—skin cancer	0.000139	0.000474	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000138	0.00132	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000138	0.000471	CcSEcCtD
Boceprevir—Insomnia—Docetaxel—skin cancer	0.000137	0.000467	CcSEcCtD
Boceprevir—Paraesthesia—Docetaxel—skin cancer	0.000136	0.000464	CcSEcCtD
Boceprevir—Nausea—Temozolomide—skin cancer	0.000135	0.000462	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—skin cancer	0.000135	0.000461	CcSEcCtD
Boceprevir—Vomiting—Fluorouracil—skin cancer	0.000133	0.000455	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—skin cancer	0.000133	0.000455	CcSEcCtD
Boceprevir—Rash—Fluorouracil—skin cancer	0.000132	0.000452	CcSEcCtD
Boceprevir—Dermatitis—Fluorouracil—skin cancer	0.000132	0.000451	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—skin cancer	0.000131	0.000449	CcSEcCtD
Boceprevir—Headache—Fluorouracil—skin cancer	0.000131	0.000449	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—skin cancer	0.000131	0.000446	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—skin cancer	0.00013	0.000446	CcSEcCtD
Boceprevir—Constipation—Docetaxel—skin cancer	0.000129	0.000442	CcSEcCtD
Boceprevir—Pain—Docetaxel—skin cancer	0.000129	0.000442	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—KRAS—skin cancer	0.000125	0.00119	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—skin cancer	0.000125	0.00119	CbGpPWpGaD
Boceprevir—Feeling abnormal—Docetaxel—skin cancer	0.000125	0.000426	CcSEcCtD
Boceprevir—Nausea—Fluorouracil—skin cancer	0.000124	0.000425	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—skin cancer	0.000124	0.000423	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRAS—skin cancer	0.00012	0.00114	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—skin cancer	0.00012	0.00114	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—skin cancer	0.00012	0.00114	CbGpPWpGaD
Boceprevir—Body temperature increased—Docetaxel—skin cancer	0.00012	0.000409	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—skin cancer	0.00012	0.000409	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRAS—skin cancer	0.000115	0.0011	CbGpPWpGaD
Boceprevir—Hypersensitivity—Docetaxel—skin cancer	0.000111	0.000381	CcSEcCtD
Boceprevir—Asthenia—Docetaxel—skin cancer	0.000109	0.000371	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—skin cancer	0.000107	0.000366	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—HRAS—skin cancer	0.000106	0.00101	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—skin cancer	0.000106	0.00101	CbGpPWpGaD
Boceprevir—Diarrhoea—Docetaxel—skin cancer	0.000103	0.000354	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KRAS—skin cancer	0.000103	0.000984	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TERT—skin cancer	0.000102	0.000971	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—skin cancer	0.000102	0.00097	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—skin cancer	0.000102	0.00097	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—skin cancer	0.000101	0.000967	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—skin cancer	0.000101	0.000967	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.0001	0.000953	CbGpPWpGaD
Boceprevir—Dizziness—Docetaxel—skin cancer	0.0001	0.000342	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KRAS—skin cancer	9.92e-05	0.000945	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—skin cancer	9.89e-05	0.000942	CbGpPWpGaD
Boceprevir—Vomiting—Docetaxel—skin cancer	9.62e-05	0.000329	CcSEcCtD
Boceprevir—Rash—Docetaxel—skin cancer	9.54e-05	0.000326	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—skin cancer	9.53e-05	0.000326	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—NRAS—skin cancer	9.49e-05	0.000904	CbGpPWpGaD
Boceprevir—Headache—Docetaxel—skin cancer	9.48e-05	0.000324	CcSEcCtD
Boceprevir—Nausea—Docetaxel—skin cancer	8.98e-05	0.000307	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—HRAS—skin cancer	8.78e-05	0.000837	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—skin cancer	8.51e-05	0.000811	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—skin cancer	8.44e-05	0.000804	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—skin cancer	8.44e-05	0.000804	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—skin cancer	8.43e-05	0.000804	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—skin cancer	8.41e-05	0.000801	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—skin cancer	8.17e-05	0.000778	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BRAF—skin cancer	8.07e-05	0.000769	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—skin cancer	7.26e-05	0.000692	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—skin cancer	7.26e-05	0.000692	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—skin cancer	7.23e-05	0.000689	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	7.1e-05	0.000676	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—skin cancer	6.99e-05	0.000666	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—skin cancer	6.95e-05	0.000662	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—skin cancer	6.92e-05	0.00066	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLIN2—skin cancer	6.55e-05	0.000624	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—skin cancer	6.17e-05	0.000588	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—skin cancer	6.17e-05	0.000588	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—skin cancer	6.02e-05	0.000573	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—skin cancer	5.91e-05	0.000563	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—skin cancer	5.91e-05	0.000563	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—skin cancer	5.76e-05	0.000549	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CSPG4—skin cancer	5.28e-05	0.000503	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—skin cancer	5.12e-05	0.000487	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—skin cancer	5.07e-05	0.000483	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	5.07e-05	0.000483	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—skin cancer	4.96e-05	0.000472	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLIN2—skin cancer	4.94e-05	0.000471	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—skin cancer	4.9e-05	0.000466	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—skin cancer	4.37e-05	0.000416	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—skin cancer	4.21e-05	0.000401	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—skin cancer	4.03e-05	0.000384	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CSPG4—skin cancer	3.98e-05	0.00038	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—skin cancer	3.88e-05	0.00037	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—skin cancer	3.71e-05	0.000354	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO2—skin cancer	3.59e-05	0.000342	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—skin cancer	3.55e-05	0.000338	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.4e-05	0.000324	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLIN2—skin cancer	3.05e-05	0.00029	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	3.02e-05	0.000288	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO2—skin cancer	2.71e-05	0.000258	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CSPG4—skin cancer	2.45e-05	0.000234	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ERCC2—skin cancer	2.08e-05	0.000199	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO2—skin cancer	1.67e-05	0.000159	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ERCC2—skin cancer	1.57e-05	0.00015	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—skin cancer	1.25e-05	0.000119	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ERCC2—skin cancer	9.69e-06	9.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—skin cancer	9.43e-06	8.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—skin cancer	5.81e-06	5.54e-05	CbGpPWpGaD
